Literature DB >> 10065680

Risk factors for community-acquired pneumonia in adults: a population-based case-control study.

J Almirall1, I Bolíbar, X Balanzó, C A González.   

Abstract

Although community-acquired pneumonia (CAP) remains a major cause of hospitalization and death, few studies on risk factors have been performed. A population-based case-control study of risk factors for CAP was carried out in a mixed residential-industrial urban area of 74,610 adult inhabitants in the Maresme (Barcelona, Spain) between 1993 and 1995. All patients living in the area and clinically suspected of having CAP at primary care facilities and hospitals were registered. In total, 205 patients with symptoms, signs and radiographic infiltrate compatible with acute CAP participated in the study. They were matched by municipality, sex and age with 475 controls randomly selected from the municipal census. Risk factors relating the subject's characteristics and habits, housing conditions, medical history and treatments were investigated by means of a questionnaire. In the univariate analysis, an increased risk of CAP was associated with low body mass index, smoking, respiratory infection, previous pneumonia, chronic lung disease, lung tuberculosis, asthma, treated diabetes, chronic liver disease, and treatments with aminophiline, aerosols and plastic pear-spacers. In multivariate models, the only statistically significant risk factors were current smoking of >20 cigarettes x day(-1) (odds ratio (OR)=2.77; 95% confidence interval (CI) 1.14-6.70 compared with never-smokers), previous respiratory infection (OR=2.73; 95% CI 1.75-4.26), and chronic bronchitis (OR=2.22; 95% CI 1.13-4.37). Benzodiazepines were found to be protective in univariate and multivariate analysis (OR=0.46; 95% CI 0.23-0.94). This population-based study provides new and better established evidence on the factors associated with the occurrence of pneumonia in the adult community.

Entities:  

Mesh:

Year:  1999        PMID: 10065680     DOI: 10.1183/09031936.99.13234999

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  67 in total

1.  Antibiotic prescribing and admissions with major suppurative complications of respiratory tract infections: a data linkage study.

Authors:  Paul Little; Louise Watson; Stephen Morgan; Ian Williamson
Journal:  Br J Gen Pract       Date:  2002-03       Impact factor: 5.386

Review 2.  Pneumonia and pregnancy.

Authors:  W S Lim; J T Macfarlane; C L Colthorpe
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

3.  Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

Authors:  Dennis Chen; Marcos I Restrepo; Michael J Fine; Mary Jo V Pugh; Antonio Anzueto; Mark L Metersky; Brandy Nakashima; Chester Good; Eric M Mortensen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

Review 4.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

5.  Regular cannabis use, with and without tobacco co-use, is associated with respiratory disease.

Authors:  Theresa Winhusen; Jeff Theobald; David C Kaelber; Daniel Lewis
Journal:  Drug Alcohol Depend       Date:  2019-09-16       Impact factor: 4.492

6.  Incidence and causes of non-invasive mechanical ventilation failure after initial success.

Authors:  M Moretti; C Cilione; A Tampieri; C Fracchia; A Marchioni; S Nava
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

7.  Association of COPD With Risk for Pulmonary Infections Requiring Hospitalization in HIV-Infected Veterans.

Authors:  Engi F Attia; Kathleen A McGinnis; Laura C Feemster; Kathleen M Akgün; Adeel A Butt; Christopher J Graber; Michael J Fine; Matthew B Goetz; Maria C Rodriguez-Barradas; Margaret A Pisani; Hilary A Tindle; Sheldon T Brown; Guy W Soo Hoo; David Rimland; Cynthia L Gibert; Laurence Huang; Matthew S Freiberg; Catherine L Hough; Kristina Crothers
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

Review 8.  Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.

Authors:  T T Dang; S R Majumdar; T J Marrie; D T Eurich
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

9.  Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community.

Authors:  Kuo-Chin Chang; Pei-Shan Tsai; Mei-Chin Hsu; Shu-Fen Hung; Chin-Chen Tsai; Sheng-Nan Lu
Journal:  J Gastroenterol       Date:  2010-01-07       Impact factor: 7.527

10.  Pharmacotherapy and the risk for community-acquired pneumonia.

Authors:  Jen-Tzer Gau; Utkarsh Acharya; Salman Khan; Victor Heh; Lona Mody; Tzu-Cheg Kao
Journal:  BMC Geriatr       Date:  2010-07-06       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.